Available Online: 28 Dec 2025
Volume 1
Javier Burgos-Salcedo
jdariob@sanmateo.edu.co
Published: 27 Oct 2025
Volume 1
Koki Yoshimoto
yoshimoto.koki.5a@kyoto-u.ac.jp
Ririka Okaichi
2210330032b@kindai.ac.jp
Kei Iida
kiida@life.kindai.ac.jp
Shiho Terada
sterada@icems.kyoto-u.ac.jp
Ken-ichiro Kamei
kk4801@nyu.edu
Published: 26 May 2025
Volume 1
Neelabh Datta
neelabh24@iisertvm.ac.in
The therapeutic potential of biomacromolecules in treating various diseases is undeniable; however, their application is significantly limited by the inherent barrier function of the cell membrane. Cell-penetrating peptides (CPPs), a class of small peptides comprising fewer than 30 amino acids, have garnered considerable attention due to their exceptional ability to traverse cell membranes. These peptides ease the intracellular delivery of various macromolecules, such as proteins, polypeptides, and nucleic acids, thereby..
Published: 28 Apr 2025
Volume 1
Nosayba Al-Damook
nosayba.aldamook@aau.ac.ae
Molham Sakkal
mohammad.sakkal@aau.ac.ae
Sedra Kremesh
sedra.kremish@gmail.com
Walaa K. Mousa
walaa.mousa@aau.ac.ae
Mostafa Khair
mrk6@nyu.edu
Ghalia Khoder
gkhoder@sharjah.ac.ae
Rose Ghemrawi
rose.ghemrawi@aau.ac.ae
Cancer cells sustain rapid growth by reprogramming their metabolism to depend heavily on glycolysis, enhanced insulin signaling, and adaptive changes in the unfolded protein response (UPR). Insulin Potentiation Therapy (IPT) enhances the efficacy of chemotherapy by increasing insulin receptor expression, thereby improving the uptake of chemotherapeutic agents. Meanwhile, targeting endoplasmic reticulum (ER) stress disrupts the protein-folding machinery within cancer cells, steering them toward apoptosis. However, IPT faces several limitations, including..
Published: 21 Mar 2025
Volume 1
Dia Advani
dia.jotwani@dubaihealth.ae
Joaquin Villarreal Barragan
100065160@ku.ac.ae
Gianina Statache
gianina.s@adscc.ae
Nadir Kadri
nadir.kadri@ki.se
Nupur Kohli
nupur.kohli@ku.ac.ae
Published: 28 Feb 2025
Volume 1
Rashik Chand
rc4400@nyu.edu
Ken-ichiro Kamei
kk4801@nyu.edu
Sanjairaj Vijayavenkataraman
vs89@nyu.edu
Published: 11 Oct 2024
Volume 1
Ken-ichiro Kamei
kk4801@nyu.edu
As the Editor-in-Chief of Cell Engineering Connect, it is both an honor and a privilege to introduce this inaugural issue. Our journal is dedicated to exploring the latest advancements in the rapidly evolving field of cell engineering, an interdisciplinary domain that holds the key to transformative innovations in healthcare, biotechnology, and synthetic biology. The convergence of cell biology, bioengineering, and data science is enabling researchers to manipulate cellular systems in..